胰島素注射器的全球市場 2022-2026
市場調查報告書
商品編碼
1135723

胰島素注射器的全球市場 2022-2026

Global Insulin Syringes Market 2022-2026

出版日期: | 出版商: TechNavio | 英文 120 Pages | 訂單完成後即時交付

價格

胰島素注射器的市場規模在2022年~2026年間,預測將成長到4億867萬美元,在預測期間內預計將以4.69%的年複合成長率增長。本報告提供胰島素注射器市場整體分析,提供市場規模與預測,趨勢,成長促進因素·課題,網羅了約25家供應商的供應商分析等資訊。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。

市場成長的主要因素有糖尿病的全球負擔的增加,政府的有利的配合措施,糖尿病自我管理教育計劃的利用可能性。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模 2021
  • 市場預測:2021-2026年的預測

第4章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

第5章 各疾病類型的市場區隔

  • 市場明細
  • 各病型比較
  • 第二型糖尿病 - 市場規模與預測 2021-2026
  • 第一型糖尿病 - 市場規模與預測 2021-2026
  • 各疾病的市場機會

第6章 客戶形勢

  • 客戶形勢概要

第7章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 - 市場規模與預測 2021-2026
  • 歐洲 - 市場規模與預測 2021-2026
  • APAC - 市場規模與預測 2021-2026
  • 南美 - 市場規模與預測 2021-2026
  • 中東及非洲 - 市場規模與預測 2021-2026
  • 美國 - 市場規模與預測 2021-2026
  • 加拿大 - 市場規模與預測 2021-2026
  • 德國 - 市場規模與預測 2021-2026
  • 中國 - 市場規模與預測 2021-2026
  • 法國 - 市場規模與預測 2021-2026
  • 各地區形勢的市場機會

第8章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • B. Braun SE
  • Becton Dickinson and Co.
  • Cardinal Health Inc
  • CODAN Medizinische Gerate GmbH and Co KG
  • Gerresheimer AG
  • Hindustan Syringes and Medical Devices Ltd.
  • Nipro Corp.
  • SCHOTT AG
  • Smiths Group Plc
  • Terumo Corp.

第11章 附錄

Product Code: IRTNTR74367

Technavio has been monitoring the insulin syringes market and it is poised to grow by $ 408.67 mn during 2022-2026, accelerating at a CAGR of 4.69% during the forecast period. Our report on the insulin syringes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes, favorable government initiatives, and the availability of diabetes self-management education programs.

The insulin syringes market analysis includes type segment and geographic landscape.

Technavio's insulin syringes market is segmented as below:

By Type

  • Type 2 diabetes
  • Type 1 diabetes

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa

This study identifies the increase in awareness programs for diabetes as one of the prime reasons driving the insulin syringes market growth during the next few years. Also, rising strategic partnerships to boost sales of insulin syringes and increasing focus on smart insulin syringes will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the insulin syringes market covers the following areas:

  • Insulin syringes market sizing
  • Insulin syringes market forecast
  • Insulin syringes market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insulin syringes market vendors that include AdvaCare Pharma, ASP Healthcare Pty Ltd., Avantor Inc., B. Braun SE, Becton Dickinson and Co., Cardinal Health Inc, CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Healthwarehouse.com Inc., Hi-Tech Medics Pvt Ltd., Hindustan Syringes and Medical Devices Ltd., LAC Healthcare Solutions, Nipro Corp., Novo Nordisk AS, Poly Medicure Ltd., SCHOTT AG, Smiths Group Plc, Terumo Corp., Thermo Fisher Scientific Inc., and UltiMed Inc. Also, the insulin syringes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Disease Type
  • Exhibit 26: Chart on Comparison by Disease Type
  • Exhibit 27: Data Table on Comparison by Disease Type
  • 5.3 Type 2 diabetes - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
  • 5.4 Type 1 diabetes - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Disease Type
  • Exhibit 36: Market opportunity by Disease Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 APAC - Market size and forecast 2021-2026
  • Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
  • 7.6 South America - Market size and forecast 2021-2026
  • Exhibit 54: Chart on South America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on South America - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on South America - Year-over-year growth 2021-2026 (%)
  • 7.7 Middle East and Africa - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
  • 7.8 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.9 Canada - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.10 Germany - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
  • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 France - Market size and forecast 2021-2026
  • Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.13 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 B. Braun SE
  • Exhibit 89: B. Braun SE - Overview
  • Exhibit 90: B. Braun SE - Business segments
  • Exhibit 91: B. Braun SE - Key news
  • Exhibit 92: B. Braun SE - Key offerings
  • Exhibit 93: B. Braun SE - Segment focus
  • 10.4 Becton Dickinson and Co.
  • Exhibit 94: Becton Dickinson and Co. - Overview
  • Exhibit 95: Becton Dickinson and Co. - Business segments
  • Exhibit 96: Becton Dickinson and Co. - Key news
  • Exhibit 97: Becton Dickinson and Co. - Key offerings
  • Exhibit 98: Becton Dickinson and Co. - Segment focus
  • 10.5 Cardinal Health Inc
  • Exhibit 99: Cardinal Health Inc - Overview
  • Exhibit 100: Cardinal Health Inc - Business segments
  • Exhibit 101: Cardinal Health Inc - Key news
  • Exhibit 102: Cardinal Health Inc - Key offerings
  • Exhibit 103: Cardinal Health Inc - Segment focus
  • 10.6 CODAN Medizinische Gerate GmbH and Co KG
  • Exhibit 104: CODAN Medizinische Gerate GmbH and Co KG - Overview
  • Exhibit 105: CODAN Medizinische Gerate GmbH and Co KG - Product / Service
  • Exhibit 106: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
  • 10.7 Gerresheimer AG
  • Exhibit 107: Gerresheimer AG - Overview
  • Exhibit 108: Gerresheimer AG - Business segments
  • Exhibit 109: Gerresheimer AG - Key news
  • Exhibit 110: Gerresheimer AG - Key offerings
  • Exhibit 111: Gerresheimer AG - Segment focus
  • 10.8 Hindustan Syringes and Medical Devices Ltd.
  • Exhibit 112: Hindustan Syringes and Medical Devices Ltd. - Overview
  • Exhibit 113: Hindustan Syringes and Medical Devices Ltd. - Product / Service
  • Exhibit 114: Hindustan Syringes and Medical Devices Ltd. - Key offerings
  • 10.9 Nipro Corp.
  • Exhibit 115: Nipro Corp. - Overview
  • Exhibit 116: Nipro Corp. - Business segments
  • Exhibit 117: Nipro Corp. - Key offerings
  • Exhibit 118: Nipro Corp. - Segment focus
  • 10.10 SCHOTT AG
  • Exhibit 119: SCHOTT AG - Overview
  • Exhibit 120: SCHOTT AG - Business segments
  • Exhibit 121: SCHOTT AG - Key news
  • Exhibit 122: SCHOTT AG - Key offerings
  • Exhibit 123: SCHOTT AG - Segment focus
  • 10.11 Smiths Group Plc
  • Exhibit 124: Smiths Group Plc - Overview
  • Exhibit 125: Smiths Group Plc - Business segments
  • Exhibit 126: Smiths Group Plc - Key news
  • Exhibit 127: Smiths Group Plc - Key offerings
  • Exhibit 128: Smiths Group Plc - Segment focus
  • 10.12 Terumo Corp.
  • Exhibit 129: Terumo Corp. - Overview
  • Exhibit 130: Terumo Corp. - Business segments
  • Exhibit 131: Terumo Corp. - Key news
  • Exhibit 132: Terumo Corp. - Key offerings
  • Exhibit 133: Terumo Corp. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 134: Inclusions checklist
  • Exhibit 135: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 136: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 137: Research methodology
  • Exhibit 138: Validation techniques employed for market sizing
  • Exhibit 139: Information sources
  • 11.5 List of abbreviations
  • Exhibit 140: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Disease Type
  • Exhibits27: Data Table on Comparison by Disease Type
  • Exhibits28: Chart on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Disease Type ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on APAC - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on South America - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on South America - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on South America - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: B. Braun SE - Overview
  • Exhibits90: B. Braun SE - Business segments
  • Exhibits91: B. Braun SE - Key news
  • Exhibits92: B. Braun SE - Key offerings
  • Exhibits93: B. Braun SE - Segment focus
  • Exhibits94: Becton Dickinson and Co. - Overview
  • Exhibits95: Becton Dickinson and Co. - Business segments
  • Exhibits96: Becton Dickinson and Co. - Key news
  • Exhibits97: Becton Dickinson and Co. - Key offerings
  • Exhibits98: Becton Dickinson and Co. - Segment focus
  • Exhibits99: Cardinal Health Inc - Overview
  • Exhibits100: Cardinal Health Inc - Business segments
  • Exhibits101: Cardinal Health Inc - Key news
  • Exhibits102: Cardinal Health Inc - Key offerings
  • Exhibits103: Cardinal Health Inc - Segment focus
  • Exhibits104: CODAN Medizinische Gerate GmbH and Co KG - Overview
  • Exhibits105: CODAN Medizinische Gerate GmbH and Co KG - Product / Service
  • Exhibits106: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
  • Exhibits107: Gerresheimer AG - Overview
  • Exhibits108: Gerresheimer AG - Business segments
  • Exhibits109: Gerresheimer AG - Key news
  • Exhibits110: Gerresheimer AG - Key offerings
  • Exhibits111: Gerresheimer AG - Segment focus
  • Exhibits112: Hindustan Syringes and Medical Devices Ltd. - Overview
  • Exhibits113: Hindustan Syringes and Medical Devices Ltd. - Product / Service
  • Exhibits114: Hindustan Syringes and Medical Devices Ltd. - Key offerings
  • Exhibits115: Nipro Corp. - Overview
  • Exhibits116: Nipro Corp. - Business segments
  • Exhibits117: Nipro Corp. - Key offerings
  • Exhibits118: Nipro Corp. - Segment focus
  • Exhibits119: SCHOTT AG - Overview
  • Exhibits120: SCHOTT AG - Business segments
  • Exhibits121: SCHOTT AG - Key news
  • Exhibits122: SCHOTT AG - Key offerings
  • Exhibits123: SCHOTT AG - Segment focus
  • Exhibits124: Smiths Group Plc - Overview
  • Exhibits125: Smiths Group Plc - Business segments
  • Exhibits126: Smiths Group Plc - Key news
  • Exhibits127: Smiths Group Plc - Key offerings
  • Exhibits128: Smiths Group Plc - Segment focus
  • Exhibits129: Terumo Corp. - Overview
  • Exhibits130: Terumo Corp. - Business segments
  • Exhibits131: Terumo Corp. - Key news
  • Exhibits132: Terumo Corp. - Key offerings
  • Exhibits133: Terumo Corp. - Segment focus
  • Exhibits134: Inclusions checklist
  • Exhibits135: Exclusions checklist
  • Exhibits136: Currency conversion rates for US$
  • Exhibits137: Research methodology
  • Exhibits138: Validation techniques employed for market sizing
  • Exhibits139: Information sources
  • Exhibits140: List of abbreviations